Evaluation of the effects of homologous platelet gel on healing lower extremity wounds in patients with diabetes

International Journal of Lower Extremity Wounds

Volumn 12, Issue 1, 2013, Pages 22-29

  Shan, Gui Qiu ^a,b   Zhang, Ya Ni ^b   Ma, Jing ^b   Li, Yan Hui ^b   Zuo, Da Ming ^a   Qiu, Jin Lang ^b   Cheng, Biao ^b,c   Chen, Zheng Liang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^c PLA   (China)

Author keywords

diabetic lower extremity wounds; homologous; migration; platelet rich plasma; proliferation

Indexed keywords

ETHACRIDINE LACTATE; PSEUDOMONIC ACID; THROMBOCYTE CONCENTRATE; WOUND HEALING PROMOTING AGENT;

ADULT; AGED; APHERESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; DIABETIC FOOT; EPITHELIZATION; FEMALE; GEL; HUMAN; KERATINOCYTE; LEG INJURY; MALE; PLATELET GEL; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA; THROMBOCYTOPHERESIS; ULCER HEALING; VACUUM ASPIRATION; VASCULARIZATION; WOUND HEALING;

AGED; AGED, 80 AND OVER; CELL LINE; DIABETIC FOOT; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; GELS; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; PLATELET-RICH PLASMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; WOUND HEALING;

EID: 84875248206     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734613477113     Document Type: Article

References (30)

1. Fang RC, Galiano RD. A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics. 2008 ; 2: 1-12
2. Hunt D. Diabetes: foot ulcers and amputations. Am Fam Physician. 2009 ; 80: 789
3. Vamos EP, Bottle A, Majeed A, Millett C. Trends in lower extremity amputations in people with and without diabetes in England, 1996-2005. Diabetes Res Clin Pract. 2010 ; 87: 275-282
4. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005 ; 366: 1736-1743
5. Papanas N, Maltezos E. Becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Clin Interv Aging. 2008 ; 3: 233-240
6. Brem H, Sheehan P, Boulton AJ. Protocol for treatment of diabetic foot ulcers. Am J Surg. 2004 ; 187: 1S - 10S
7. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet. 2005 ; 366: 1725-1735
8. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 1994 ; 83: 113-118
9. Fivenson DP, Faria DT, Nickoloff BJ, et al. Chemokine and inflammatory cytokine changes during chronic wound healing. Wound Repair Regen. 1997 ; 5: 310-322
10. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Healing diabetic neuropathic foot ulcers: are we getting better?. Diabet Med. 2005 ; 22: 172-176
11. Akingboye AA, Giddins S, Gamston P, Tucker A, Navsaria H, Kyriakides C. Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer. J Extra Corpor Technol. 2010 ; 42: 20-29
12. Chen TM, Tsai JC, Burnouf T. A novel technique combining platelet gel, skin graft, and fibrin glue for healing recalcitrant lower extremity ulcers. Dermatol Surg. 2010 ; 36: 453-460
13. Driver VR, Hanft J, Fylling CP, Beriou JM. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006 ; 52: 68-70
14. Borzini P, Mazzucco L. Platelet gels and releasates. Curr Opin Hematol. 2005 ; 12: 473-479
15. Anitua E, Sanchez M, Nurden AT, Nurden P, Orive G, Andía I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006 ; 24: 227-234
16. Frei R, Biosca FE, Handl M, Trc T. The role of growth factors in the human organism and their use in medicine, especially in orthopedics and traumatology. Acta Chir Orthop Traumatol Cech. 2008 ; 75: 247-252
17. Su CY, Kuo YP, Nieh HL, Tseng YH, Burnouf T. Quantitative assessment of the kinetics of growth factors release from platelet gel. Transfusion. 2008 ; 48: 2414-2420
18. Jeong SH, Han SK, Kim WK. Treatment of diabetic foot ulcers using a blood bank platelet concentrate. Plast Reconstr Surg. 2010 ; 125: 944-952
19. Deng Q, Wang Q, Zong WY, et al. E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation. Cancer Res. 2010 ; 70: 782-791
20. Ranzato E, Patrone M, Mazzucco L, Burlando B. Platelet lysate stimulates wound repair of HaCaT keratinocytes. Br J Dermatol. 2008 ; 159: 537-545
21. Giusti I, Rughetti A, D'Ascenzo S, et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion. 2009 ; 49: 771-778
22. Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999 ; 7: 442-452
23. Bernuzzi G, Tardito S, Bussolati O, et al. Platelet gel in the treatment of cutaneous ulcers: the experience of the Immunohaematology and Transfusion Centre of Parma. Blood Transfus. 2010 ; 8: 237-247
24. Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med. 2010 ; 83: 1-9
25. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg. 2003 ; 90: 133-146
26. Balfour JA, Noble S. Becaplermin. BioDrugs. 1999 ; 11: 359-364
27. McAleer JP, Sharma S, Kaplan EM, Persich G. Use of autologous platelet concentrate in a nonhealing lower extremity wound. Adv Skin Wound Care. 2006 ; 19: 354-363
28. O'Connell SM, Impeduglia T, Hessler K, Wang XJ, Carroll RJ, Dardik H. Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers. Wound Repair Regen. 2008 ; 16: 749-756
29. Guide to the Preparation, Use and Quality Assurance of Blood Components. 10 th ed.Strasbourg, France: Council of Europe Publishing; 2004. Strasbourg, France: Council of Europe Publishing ; 2004 :
30. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004 ; 91: 4-15